Allarity Therapeutics (ALLR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.89, +7.44% vs the prior close of $0.83.
- Volume 215.80K shares, 2.0x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ALLR jumps 7.4% to $0.89 on 2.0x normal volume. Closed at $0.89, +7.44% vs the prior close of $0.83. Day range $0.82–$0.92, opened at $0.85.
ALLR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ALLR jumps 7.4% to $0.89 on 2.0x normal volume
- Closed at $0.89, +7.44% vs the prior close of $0.83. Day range $0.82–$0.92, opened at $0.85.
- Volume was 215.80K shares, 2.0x its 50-day average of 109.43K — unusually heavy trading.
- Price is -25.2% vs its 50-day average ($1.20) and -27.3% vs its 200-day average ($1.23).
- 52-week range $0.77–$1.84; today's close sits at 12% of that range, 51.4% below the 52-week high.
Oct 15, 2026 — ALLR slides 4.6% to $0.83, a 6-month low on 3.1x normal volume
- Closed at $0.83, -4.58% vs the prior close of $0.87. Day range $0.80–$0.90, opened at $0.90.
- Volume was 322.80K shares, 3.1x its 50-day average of 105.13K — unusually heavy trading.
- Price is -31.0% vs its 50-day average ($1.21) and -32.4% vs its 200-day average ($1.23).
- 52-week range $0.77–$1.84; today's close sits at 6% of that range, 54.7% below the 52-week high.
Oct 14, 2026 — ALLR rises 0.3% to $0.87
- Closed at $0.87, +0.34% vs the prior close of $0.87. Day range $0.86–$0.89, opened at $0.88.
- Volume was 64.00K shares, 0.6x its 50-day average of 106.20K.
- Price is -28.2% vs its 50-day average ($1.22) and -29.2% vs its 200-day average ($1.23).
- 52-week range $0.77–$1.84; today's close sits at 10% of that range, 52.6% below the 52-week high.
Oct 13, 2026 — ALLR rises 1.2% to $0.87
- Closed at $0.87, +1.16% vs the prior close of $0.86. Day range $0.83–$0.91, opened at $0.88.
- Volume was 111.40K shares, 1.1x its 50-day average of 105.27K.
- Price is -29.0% vs its 50-day average ($1.23) and -29.5% vs its 200-day average ($1.23).
- 52-week range $0.77–$1.84; today's close sits at 9% of that range, 52.7% below the 52-week high.
Oct 12, 2026 — ALLR slides 13.1% to $0.86, a 6-month low on 4.2x normal volume
- Closed at $0.86, -13.13% vs the prior close of $0.99. Day range $0.83–$0.99, opened at $0.97.
- Volume was 415.20K shares, 4.2x its 50-day average of 97.76K — unusually heavy trading.
- Price is -30.3% vs its 50-day average ($1.23) and -30.3% vs its 200-day average ($1.23).
- 52-week range $0.77–$1.84; today's close sits at 8% of that range, 53.3% below the 52-week high.
Oct 9, 2026 — ALLR rises 0.8% to $0.99
- Closed at $0.99, +0.81% vs the prior close of $0.98. Day range $0.99–$1.04, opened at $1.00.
- Volume was 97.00K shares, 1.0x its 50-day average of 96.94K.
- Price is -20.2% vs its 50-day average ($1.24) and -19.9% vs its 200-day average ($1.24).
- 52-week range $0.77–$1.84; today's close sits at 21% of that range, 46.2% below the 52-week high.
Oct 8, 2026 — ALLR ends flat (-0.2%) to $0.98, 6 down days in a row
- Closed at $0.98, -0.20% vs the prior close of $0.98. Day range $0.95–$1.00, opened at $1.00.
- Volume was 63.50K shares, 0.7x its 50-day average of 96.79K.
- Price is -21.1% vs its 50-day average ($1.25) and -20.5% vs its 200-day average ($1.24).
- 52-week range $0.77–$1.84; today's close sits at 20% of that range, 46.6% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — ALLR ends flat (-0.1%) to $0.98, 5 down days in a row
- Closed at $0.98, -0.10% vs the prior close of $0.99. Day range $0.98–$1.04, opened at $1.02.
- Volume was 81.00K shares, 0.8x its 50-day average of 96.81K.
- Price is -21.2% vs its 50-day average ($1.25) and -20.4% vs its 200-day average ($1.24).
- 52-week range $0.77–$1.84; today's close sits at 20% of that range, 46.5% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — ALLR dips 1.5% to $0.99, 4 down days in a row
- Closed at $0.99, -1.50% vs the prior close of $1.00. Day range $0.98–$1.00, opened at $0.98.
- Volume was 45.30K shares, 0.5x its 50-day average of 96.40K — lighter than usual.
- Price is -21.4% vs its 50-day average ($1.25) and -20.3% vs its 200-day average ($1.24).
- 52-week range $0.77–$1.84; today's close sits at 20% of that range, 46.5% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — ALLR slides 3.8% to $1.00, 3 down days in a row
- Closed at $1.00, -3.85% vs the prior close of $1.04. Day range $0.99–$1.05, opened at $1.04.
- Volume was 39.10K shares, 0.4x its 50-day average of 96.49K — lighter than usual.
- Price is -20.5% vs its 50-day average ($1.26) and -19.1% vs its 200-day average ($1.24).
- 52-week range $0.77–$1.84; today's close sits at 22% of that range, 45.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — ALLR ends flat (+0.0%) to $1.04
- Closed at $1.04, +0.00% vs the prior close of $1.04. Day range $1.03–$1.08, opened at $1.05.
- Volume was 28.90K shares, 0.3x its 50-day average of 96.81K — lighter than usual.
- Price is -17.6% vs its 50-day average ($1.26) and -15.9% vs its 200-day average ($1.24).
- 52-week range $0.77–$1.84; today's close sits at 25% of that range, 43.5% below the 52-week high.
ALLR latest news & SEC filings
Every SEC filing by or about ALLR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Graff Jeremy R. converted options/RSUs into 48,147 shares on Jan 22, 2026; now holds 73,028
- Graff Jeremy R. had withheld for taxes 17,814 shares at $1.18 (≈$21.02K) on Jan 22, 2026; now holds 55,214
- Graff Jeremy R. converted options/RSUs into 39,494 shares on Sep 30, 2026; now holds 94,708
- Graff Jeremy R. had withheld for taxes 14,613 shares at $0.97 (≈$14.17K) on Sep 30, 2026; now holds 80,095
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.40M (prior year -$2.32M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.21 (prior year -$0.15) (loss widened vs Jun 30, 2025)
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
- Item 8.01 — Reported other events the company considers important.
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade ALLR
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: Apr 1, 2026, May 9, 2025, Mar 31, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.71% (largest 13.1%). That is a volatile stock.
- Liquidity: about 134.99K shares (≈$120.81K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.89 vs a range of $0.77–$1.84 (12% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 1, 2026; 8-K Sep 29, 2026; 8-K Sep 16, 2026.
- Share count: 15.91M shares outstanding (Aug 14, 2026), +8.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ALLR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.85 | 0.92 | 0.82 | 0.89 | 215.80K |
| Oct 15, 2026 | 0.90 | 0.90 | 0.80 | 0.83 | 322.80K |
| Oct 14, 2026 | 0.88 | 0.89 | 0.86 | 0.87 | 64.00K |
| Oct 13, 2026 | 0.88 | 0.91 | 0.83 | 0.87 | 111.40K |
| Oct 12, 2026 | 0.97 | 0.99 | 0.83 | 0.86 | 415.20K |
| Oct 9, 2026 | 1.00 | 1.04 | 0.99 | 0.99 | 97.00K |
| Oct 8, 2026 | 1.00 | 1.00 | 0.95 | 0.98 | 63.50K |
| Oct 7, 2026 | 1.02 | 1.04 | 0.98 | 0.98 | 81.00K |
| Oct 6, 2026 | 0.98 | 1.00 | 0.98 | 0.99 | 45.30K |
| Oct 5, 2026 | 1.04 | 1.05 | 0.99 | 1.00 | 39.10K |
| Oct 2, 2026 | 1.05 | 1.08 | 1.03 | 1.04 | 28.90K |
| Oct 1, 2026 | 1.06 | 1.08 | 1.01 | 1.04 | 74.10K |
| Sep 30, 2026 | 0.99 | 1.08 | 0.97 | 1.05 | 119.10K |
| Sep 29, 2026 | 0.97 | 1.00 | 0.94 | 0.96 | 167.60K |
| Sep 28, 2026 | 1.03 | 1.08 | 0.90 | 0.97 | 270.90K |
| Sep 25, 2026 | 1.09 | 1.10 | 1.03 | 1.03 | 43.70K |
| Sep 24, 2026 | 1.06 | 1.09 | 1.03 | 1.09 | 75.00K |
| Sep 23, 2026 | 1.15 | 1.15 | 1.01 | 1.04 | 167.50K |
| Sep 22, 2026 | 1.17 | 1.23 | 1.10 | 1.11 | 182.90K |
| Sep 21, 2026 | 1.20 | 1.20 | 1.13 | 1.17 | 114.90K |
About Allarity Therapeutics
Allarity Therapeutics (ALLR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOSTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1860657.
ALLR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jesper Hoeiland | Director | May 11, 2026 |
| Gerald W. Mclaughlin | Director | May 7, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jeffrey S Ervin | CFO | Apr 30, 2026 |
| Jeremy R. Graff | See Remarks | Apr 30, 2026 |
| Thomas Jensen | CEO | May 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ALLR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-11.23M | — | $-14.82M |
| Dec 31, 2024 | — | $-24.52M | — | $-17.35M |
| Dec 31, 2023 | — | $-11.90M | -10.26 | $-12.74M |
| Dec 31, 2022 | — | $-16.06M | -3,093.42 | $-16.82M |
| Dec 31, 2021 | — | $-26.65M | -4.19 | $-14.89M |
Latest balance sheet: total assets $32.12M, total liabilities $28.58M, cash $16.98M (as of Jun 30, 2026).
ALLR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $1.37 |
| Apr 1, 2026 | 8-K Item 2.02 (results) | $1.13 |
| May 9, 2025 | 8-K Item 2.02 (results) | $1.05 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $0.94 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $1.41 |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 8, 2024 | 8-K Item 2.02 (results) | — |
| Nov 15, 2022 | 8-K Item 2.02 (results) | — |
| Oct 11, 2022 | 8-K Item 2.02 (results) | — |
| Aug 22, 2022 | 8-K Item 2.02 (results) | — |
| May 27, 2022 | 8-K Item 2.02 (results) | — |
| May 17, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ALLR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.